What are the indications and survivorship of tumor endoprosthetic reconstructions for patients with extremity metastatic bone disease?

JK Kendal, CD Hamad, AG Abbott… - Journal of surgical …, 2023 - Wiley Online Library
Abstract Background and Objectives Given advances in therapies, endoprosthetic
reconstruction (EPR) in metastatic bone disease (MBD) may be increasingly indicated. The …

Metastasectomy for oligometastatic bone disease of the appendicular skeleton: A concise review

LA Kafchinski - Journal of Surgical Oncology, 2023 - Wiley Online Library
As the life expectancy of patients with carcinomas improves, there is an associated increase
in the risk of development of metastatic bone disease. Patients with solitary or …

Oncologic outcome after pulmonary metastasectomy as part of multidisciplinary treatment in a tertiary oncological center

N Motas, MD Davidescu, BC Tanase, O Rus, AI Burlacu… - Diagnostics, 2023 - mdpi.com
(1) Background: Pulmonary metastases are encountered in approximately one-third of
patients with malignancies, especially from colorectal, lung, breast, and renal cancers, and …

Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies

JE Passman, MJ Kallan, JL Roberson, SP Ginzberg… - Cancer, 2025 - Wiley Online Library
Background Metastasectomy is a useful adjunct in the management of metastatic cancer.
Widespread adoption of novel targeted and immunotherapies has improved the survival …

新发Ⅳ 期乳腺癌患者手术价值探讨

陈璐艳, 王丽雪, 傅佩芬 - 中国癌症杂志, 2023 - china-oncology.com
乳腺癌是全世界常见的恶性肿瘤之一, 其中约6% 的患者为新发Ⅳ 期乳腺癌, 是不可治愈的.
传统意义上外科手术的作用仅限于缓解患者症状, 改善生活质量, 降低肿瘤负荷 …

Treatment of the Oligometastatic Patient

M Maspero, F Albanesi, C Sposito, V Mazzaferro… - 2024 - Springer
Oligometastatic disease (OMD) is an intermediate state between localized and disseminated
cancer. Differently from polymetastatic disease in which systemic therapy is the mainstay …

Role of Surgery in Metastatic Breast Cancer and Its Justification

G Puri, C Kumar - Evidence in Breast Cancer, 2025 - Springer
Breast cancer has taken over lung cancer to be the most common cancer worldwide,
accounting for 11.7% of all cancer cases and 6.9% of all cancer deaths [1]. According to the …

[HTML][HTML] Management of patients with liver-confined, synchronous metastatic breast cancer

AJ Bartholomew, KE Rhodin, E Kanu, S Masoud… - Surgical Oncology …, 2024 - Elsevier
Introduction Approximately 5% of patients with new breast cancer diagnoses have stage IV
disease and 10% of these patients have liver-confined metastases. The surgical …

[PDF][PDF] Oncologic Outcome after Pulmonary Metastasectomy as Part of Multidisciplinary Treatment in a Tertiary Oncological Center. Diagnostics 2023, 13, 165

N Motas, MD Davidescu, BC Tanase, O Rus, AI Burlacu… - 2023 - academia.edu
(1) Background: Pulmonary metastases are encountered in approximately one-third of
patients with malignancies, especially from colorectal, lung, breast, and renal cancers, and …

Factors Influencing Prognosis in Patients with De Novo Stage IV Breast Cancer: A Systematic Review and Meta-Analysis

M Zhang, Z Jin, Y Xu, B Chen, J Song, M Li, F Jin… - De Novo, 2022 - papers.ssrn.com
Background: Identifying patients with de novo stage IV breast cancer who are likely to
achieve long-term survival and those with a poor prognosis is important. We aimed to …